Medicamentalia-Contraceptives is an international journalistic investigation by Civio on birth control access and barriers. We have combined data journalism with on-the-ground reporting to tell the stories of the women behind the statistics, to gather their opinions about birth control access and their freedom to decide about their bodies. This instalment follows in the footsteps of two predecessors, focused on access to essential medicines and access to vaccines around the world.
The next Science March will take place in Washington, Göttingen and many other cities throughout the world on the 14th April 2018. This research activism movement born last year is set to gain momentum. It is a reminder to the science community that researchers need to make their voices heard
Six years ago, the Spanish parliament approved Law 14/2011, known as the Science Law, aiming to modernise and harmonise different aspects of scientific activity in Spain, by a virtually unanimous vote. Today, Spanish scientists are still waiting for the law to be fully implemented; more than three and half years after the deadline for implementation has passed.
In this article, the 5s6s Platform, a grassroots movement of Spanish scientists, including about 400 tenured scientists working in OPIs, supported by another >1300 scientists working in different Spanish Universities and other research institutions, denounces this untenable situation and requests that the Government finally implements the law.
The world of science now lags behind the gold standard of open debate, otherwise present in politics, for instance. Particularly, when it comes to openly discussing the social issues plaguing the scientific community, such as gender inequality. Ros Herman shares her views about accountability, communication and engagement with the public.
On 8th May 2017, one of the arm of the British scientific establishment, the Royal Institution, has opened its famous lecture theatre to a debate about Brexit. Brexit is not about extricating the UK from the European scientific endeavour. And Brexit does not bring to an end many important aspects of the integrated European scientific projects. Today, it is not obvious, however, which strategies the UK–and the other EU 27 countries–could adopt to sustain as much as possible international collaborations and mobility. In this opinion piece, representatives of EuroScience argue that scientists need to raise their voices to guarantee their future and the future of our societies. Should all negotiation fail and the UK ends up with weakened relations with the EU 27, the authors argue, it remains to be seen whether the UK plan to strengthen relations and collaborations with the US, the Commonwealth and East-Asia will be an adequate substitute.
Given the size of its economy, the participation of the UK as FP Associated Country would be expensive. These are the kind of issues on which a debate entitled ‘Brexit: the scientific impact’ are due to focus on, on 8th May at the Royal Institution, London, UK.
March for Science Greece didn’t happen and here is the paradox in the land where science was born. An article by Vasiliki Michopoulou.
This article has been produced as part of a data journalism initiative called ‘Medicamentalia – Vaccines ‘ brought to you by the Civio Foundation. It outlines some of the successes in vaccination campaigns from governments across the world. It also gives you a historical perspective on the key scientists who have been instrumental in developing vaccines of the past centuries. Find out more, it makes for an insightful reading.
The MCAA and EuroScientist are hosting a round table “What can scholars do about the refugee crisis?” on February 15 2017 at 17:00 CET.
Until now, our diagnostics of the role of research and innovation in society has been too simplistic. In this opinion piece, Elisabeth Gulbrandsen, special adviser in the division for innovation of the Research Council of Norway, shares her view on how RRI can be embedded in the fabric of research programmes. She argues that RRI is a wake-up call pointing to the need to examine the nature of the research and innovation itself before we can implement a change in the culture of research, moving beyond our comfort zone.
Amidst the flurry of questions about the future of science after Brexit, another yet unanswered question also arises: What happens to how the UK regulates potentially hazardous chemicals that currently fall under EU legislation?
About a month after the British Referendum, the UK Parliament held a Parliament Links Day to communicate political plans to support UK science post-Brexit.